Prospects for the creation of an antiviral drug based on the raw material of synthetic origin
DOI:
https://doi.org/10.24959/nphj.19.2Keywords:
acute respiratory viral infections, antiviral drugs, inosine pranobexAbstract
Aim. To determine the prospects for the creation of a drug based on inosine pranobex using scientific analysis of the characteristics and range of antiviral drugs at the pharmaceutical market ofUkraine.
Materials and methods. The material of the article was literary sources of electronic and printed publications on the problems of the use of the substance of synthetic origin – inosine pranobex in modern pharmacotherapy of epidemic mumps, herpes virus human, cytomegalovirus, Epstein-Barr virus, chickenpox virus, influenza virus and parainfluenza. The results were collected and processed using the analytical-comparative, logical and systematic methods of research and the analysis of scientific publications of scientists from different countries of the world, explanation of the reasons and the conceptual position of the authors of the works analyzed on the development and application of antiviral drugs and systematization of the data collected.
Results and discussion. The substance of synthetic origin, inosine pranobex, has a direct antiviral effect due to its ability to bind to the ribosomes of infected cells, slows down the synthesis of viral RNA (transcriptional and translational impairment) and leads to inhibition of replication of RNA and DNA-genomic viruses. Induction of interferon formation is also characteristic for the drugs on the basis of this substance. The immunomodulating properties of inosine pranobex are due to the ability of the substance to enhance the differentiation of pre-T-lymphocytes, stimulate mitogen-induced proliferation of T-and B-lymphocytes, increase the functional activity of T-lymphocytes, as well as their ability to form lymphokines. The synthesis of interleukin-1, the expression of membrane receptors and the ability to respond to lymphokines and chemotactic factors are stimulated. Due to the wide range of the pharmacological action, inosine pranobex stimulates mainly cellular immunity, which is especially effective under conditions of cellular immunodeficiency. It has been also found that the use of inosine pranobex helps to reduce the severity of symptoms of herpes infection, duration of the disease; in addition, the substance studied can enhance the antiviral effect of interferon, acyclovir and other antiviral drugs. The above facts prove the relevance of the use of inosine pranobex both for the treatment and prevention of acute and chronic viral infections.
Conclusions. The article highlights the current issues of the treatment and prevention of acute respiratory viral infections at the present stage. The classification and features of the mechanism of action of common antiviral drugs are given. A comparison has been made between domestic and international data on the spectrum of application and the pharmacological safety of inosine pranobex. The studies indicate the prospects of creating production of the substance of synthetic origin – inosine pranobex inUkraine. The development of an antiviral drug based on it will significantly reduce the economic costs of industrial production and will be able to guarantee the quality of the medicinal product confirmed by clinical studies.
References
Pechinka, A. M., Dzeman, M. I. (2010). Ukrainskyi medychnyi chasopys, 5 (79), 94–103.
Kovalev, V. M., Yarnykh, T. H., Kovalev, V. M. (2018). Grounding of semisolid medicinal forms production on nature components. Zastosuvannia metodiv likuvannia i apipreparativ u medychnii, farmatsevtychnii ta kosmetychnii praktytsi : materialy vseukrainskoi naukovo–praktychnoi konferentsii z Mizhnarodnoiu uchastiu (29-30. 03. 2018). Kharkiv : “Oryhinal”, 185–190.
Tykhonov, O. I., Yarnykh, T. H., Oliinyk, S. V., Kran, O. S. (2019). “Liky – liudyni. Suchasni problemy farmakoterapii i pryznachennia likarskykh zasobiv” : materialy III Mizhnar. nauk –prakt. konf. (14–15.03.2019). Kharkiv : NFaU, 1, 218–225.
Levachkova, L. V., Yarnykh, T. G., Litvinova, O. M. (2014). Antivirals : today and the prospects of development in Ukraine. Ukraïns’kij bìofarmacevtičnij žurnal, 6, 18–22.
Rukhmakova, O. A., Yarnykh, T. H., Karpenko, I. A. (2018). Kosmetolohiia ta aromolohiia : etapy stanovlennia i maibutnie : zbirnyk naukovykh prats Mizhnarodnoi naukovo–praktychnoi konferentsii (22–23.02.2018). Kharkiv : NFaU, 57–59.
Rukhmakova, O. A., Yarnykh, T. H., Karpenko, I. A. (2018). Farmatsevtychni ta medychni nauky : aktualni pytannia: mater. mizhnar. nauk.–prakt. konf., (13–14.04. 2018). Dnipro : Orhanizatsiia naukovykh medychnykh doslidzhen “Salutem”, 98–103.
Sergienko, E. N., Shmeleva, E. P., Germanenko, I. G., Gribkova, N. V. (2010). Novosti meditciny i farmatcii v mire, 3, 12–13.
Tykhonov, O. I., Yarnykh, T. H., Kudryk, B. T., Shpychak, O. S. (2018). Aktualni problemy rozvytku haluzevoi ekonomiky ta lohistyky : materialy VI naukovo–praktychnoi konferentsii z mizhnarodnoiu uchastiu (25–26.10.2018). Kharkiv, 140–143.
Yarnykh, T. H., Rukhmakova, O. A., Melnyk, H. M., Drap, Yu. A. (2013). Funktsionalni kharchovi produkty – diietychni dobavky – yak diievyi zasib riznoplanovoi profilaktyky zakhvoriuvan : materialy I Mizhnar. nauk.–prakt. konf., (11–12.04.2013). Kharkiv : ESEN, 283–284.
Yarnykh, T. H., Levachkova, Yu. V. Chushenko, V. M. Litvinova, O. M. (2016). Farmatsiia KhKhI stolittia : tendentsii ta perspektyvy : materialy VIII Nats. zizdu farmatsevtiv Ukrainy, (13–16.09.2016). Kharkiv, 303.
Beran, J., Šalapová, E., & Špajdel, M. (2016). Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study. BMC Infectious Diseases, 16 (1). https://doi.org/10.1186/s12879-016-1965-5
Majewska, A., Lasek, W., Młynarczyk, G. (2015). Inosine pranobex – cytotoxic activities and effect of on replication of human parainfluenza viruses (HPIV–2, HPIV–4), entroviruses (CA16, EV71) and adenoviruses (HAdV–2, HAdV–5) in vitro. Med Dosw Mikrobiol, 67, 107–113.
Derzhavnyi reiestr likarskykh zasobiv Ukrainy. (n.d.). Available at : http://www.drlz.com.ua/
Mynbaev, O. A., Manukhin, I. B., Tcarev, V. N. (2010). Novosti meditciny i farmatcii. Available at : https://www.mif-ua.com/archive/article_print/14715
Denisenko, V. B., Simovanian, E. N., Grigorian, A. V. (2011). Voprosy sovremennoi pediatrii, 2, 16–21.
Krastev, Z., Jelev, D., & Ivanova, R. (2015). Isoprinosine Induces a Rapid Lympho-Mononuclear Response in Adult Participants. Journal of Medical and Dental Practice, 2 (1), 80–85. https://doi.org/10.18044/medinform.201521.80
Kozlovskii, A. A., Pyrkova, I. V. (2011). Meditcinskie novosti, 4, 11–13.
Rukhmakova, O. A., Karpenko, I. A., Yarnykh, T. G. (2018). Thermogravimetric studies of nasal gel with dry extract of licorice root and essential oils. Asian Journal of Pharmaceutical and Clinical Research, 11 (8), 85. https://doi.org/10.22159/ajpcr.2018.v11i8.24948
19. Normatyvno-dyrektyvni dokumenty MOZ Ukrainy. (n.d.). Available at : https://mozdocs.kiev.ua/likiview.php?id=22805
Lasek, W., Janyst, M., Wolny, R., Zapała, Ł., Bocian, K., & Drela, N. (2015). Immunomodulatory effects of inosine pranobex on cytokine production by human lymphocytes. Acta Pharmaceutica, 65 (2), 171–180. https://doi.org/10.1515/acph-2015-0015
You, Y., Wang, L., Li, Y., Wang, Q., Cao, S., Tu, Y., … Hao, F. (2015). Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients. The Journal of Dermatology, 42 (6), 596–601. https://doi.org/10.1111/1346-8138.12845
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
